Award
NIH Reporter #5R01CA299870-02
Towards characterization of Epigenetic targets in Prostate Cancer
Recipient
IRFAN AHMED ASANGANI
Award Amount
$371,719.00
Ceiling
$371,719.00
Awarded
February 27, 2026
Identifier
5R01CA299870-02
NIH/NCI awarded a research grant to study epigenetic targets in prostate cancer, focusing on NSD2 and AR signaling, including molecular studies and inhibitor evaluation.
Description
Research grant opportunity from the NIH/NCI focusing on epigenetic targets in prostate cancer, with a focus on NSD2 and AR signaling. The project involves molecular mechanistic studies and evaluation of small molecule inhibitors in prostate cancer models.